The results showed that the positive rate of SATB-1 staining was 86.7% (104/120) in 120 cases of prostatic carcinoma and 0% (0/60) in 60 cases of benign prostate hyperplasia. This evidence concerns the gene SATB1 and benign prostatic hyperplasia.